Published in Cancer Weekly, September 23rd, 2003
To better understand the contributions of concurrent chemotherapy to preoperative radiation therapy, researchers compared the outcomes of rectal patients who were treated at two large institutions - M.D. Anderson Cancer Center in Houston and Washington University School of Medicine in St. Louis.
During the study, researchers reviewed the hospital and radiation records of 403 patients with clinically staged T3 or T4 adenocarcinoma of the rectum who were treated at one of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-09-23)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.